Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Phio Pharmaceuticals Corp. Common Stock

PHIO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of PHIO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
PHIO Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
PHIO Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PHIO Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in PHIO holdings by institutional investors

Quarterly net insider trading by PHIO's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for PHIO

Quiver Logo

No former government officials on record as having lobbied for PHIO

Revolving Door Dashboard

PHIO Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

PHIO Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
PHIO Income Statement
PHIO Balance Sheet
PHIO Cash Flow
U.S. Patents

New PHIO patent grants

  • Patent Title: Topical delivery of nucleic acid compounds Feb. 10, 2026
  • Patent Title: Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1 Mar. 12, 2024
  • Patent Title: Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality Jun. 06, 2023
  • Patent Title: Rna interference in ocular indications Feb. 21, 2023
  • Patent Title: Neutral nanotransporters Jul. 26, 2022
  • Patent Title: Methods for treating cancer using nucleic acids targeting mdm2 or mycn Mar. 22, 2022
  • Patent Title: Inhibition of map4k4 through rnai Feb. 22, 2022
  • Patent Title: Reduced size self-delivering rnai compounds Sep. 14, 2021
  • Patent Title: Reduced size self-delivering nucleic acid compounds targeting long non-coding rna Jun. 01, 2021
  • Patent Title: Nucleic acid molecules targeting superoxide dismutase 1 (sod1) May. 11, 2021
  • Patent Title: Immunotherapy of cancer Mar. 02, 2021
  • Patent Title: Rna interference in dermal and fibrotic indications Feb. 09, 2021
  • Patent Title: Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1 Jan. 26, 2021
  • Patent Title: Reduced size self-delivering rnai compounds Dec. 29, 2020
  • Patent Title: Rna interference in skin indications Oct. 27, 2020
  • Patent Title: Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach Oct. 20, 2020
  • Patent Title: Reduced size self-delivering rnai compounds Sep. 15, 2020
  • Patent Title: Rna interference in ocular indications May. 26, 2020
  • Patent Title: Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality Nov. 19, 2019
  • Patent Title: Effective sensitizing dose of a gelled immunomodulating topical composition May. 28, 2019
  • Patent Title: Reduced size self-delivering rnai compounds Mar. 26, 2019
  • Patent Title: Rna interference in ocular indications Jan. 22, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to PHIO from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
PHIO News

Recent insights relating to PHIO

CNBC Recommendations

Recent picks made for PHIO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PHIO

PHIO Analyst Ratings

PHIO Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
PHIO Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $PHIO stock a Buy, Sell, or Hold?

  • What is the price target for $PHIO stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

PHIO Top Shareholders
Shareholder
Shares Held
PHIO Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $PHIO stock?

  • Who owns the most shares of $PHIO stock?

  • What funds own $PHIO stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

PHIO Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PHIO Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About PHIO

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

  • Address King Of Prussia, PA
  • Market Cap 11.6 million
  • Employees 6
  • Industrial Classification Pharmaceutical Preparations

Phio Pharmaceuticals Corp. Common Stock (PHIO) Historical Stock Prices

Phio Pharmaceuticals Corp. Common Stock (PHIO) closed at $1.00 on September 22, 2026. Over the past year its adjusted close ranged from $0.8568 to $2.48. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month-15.25%
  • 3 months-3.85%
  • Year to date-4.76%
  • 1 year-55.36%
  • 3 years-92.01%
  • 5 years-99.57%
  • Max-65.52%
See every congressional and insider trade on the PHIO price chart

Quiver Premium charts PHIO's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 1.02 1.05 0.9900 1.00 1.00 206,297
Sep 21, 2026 1.04 1.05 1.00 1.01 1.01 80,771
Sep 18, 2026 1.04 1.06 1.01 1.03 1.03 156,865
Sep 17, 2026 1.03 1.04 0.9883 1.02 1.02 79,454
Sep 16, 2026 1.00 1.02 0.9782 0.9991 0.9991 62,753
Sep 15, 2026 1.04 1.04 0.9900 1.02 1.02 114,805
Sep 14, 2026 1.03 1.05 1.01 1.03 1.03 67,204
Sep 11, 2026 1.03 1.05 1.02 1.03 1.03 95,587
Sep 10, 2026 1.03 1.03 0.9800 1.01 1.01 93,870
Sep 9, 2026 1.03 1.06 1.03 1.03 1.03 138,267
Sep 8, 2026 1.07 1.08 1.02 1.03 1.03 320,421
Sep 4, 2026 1.10 1.12 1.07 1.08 1.08 87,606
Sep 3, 2026 1.14 1.14 1.09 1.11 1.11 126,679
Sep 2, 2026 1.07 1.17 1.07 1.13 1.13 241,213
Sep 1, 2026 1.08 1.11 1.05 1.10 1.10 282,685
Aug 31, 2026 1.13 1.13 1.08 1.09 1.09 250,256
Aug 28, 2026 1.12 1.15 1.11 1.13 1.13 88,385
Aug 27, 2026 1.21 1.21 1.10 1.12 1.12 243,505
Aug 26, 2026 1.18 1.22 1.17 1.20 1.20 115,833
Aug 25, 2026 1.14 1.22 1.14 1.19 1.19 270,145
Aug 24, 2026 1.19 1.21 1.13 1.17 1.17 228,253
Aug 21, 2026 1.24 1.24 1.17 1.18 1.18 138,318
Aug 20, 2026 1.16 1.22 1.10 1.21 1.21 332,855
Aug 19, 2026 1.10 1.16 1.08 1.15 1.15 618,306
Aug 18, 2026 1.06 1.06 1.03 1.05 1.05 81,901
Aug 17, 2026 1.09 1.10 1.06 1.06 1.06 96,234
Aug 14, 2026 1.12 1.13 1.07 1.09 1.09 95,631
Aug 13, 2026 1.09 1.10 1.07 1.09 1.09 42,869
Aug 12, 2026 1.10 1.10 1.07 1.08 1.08 100,738
Aug 11, 2026 1.07 1.09 1.07 1.09 1.09 221,204
Aug 10, 2026 1.03 1.08 1.02 1.06 1.06 205,775
Aug 7, 2026 0.9941 1.08 0.9941 1.04 1.04 86,065
Aug 6, 2026 1.05 1.10 1.05 1.06 1.06 52,165
Aug 5, 2026 1.08 1.09 1.04 1.07 1.07 54,593
Aug 4, 2026 1.00 1.12 1.00 1.06 1.06 293,851
Aug 3, 2026 1.03 1.04 0.9970 1.03 1.03 67,888
Jul 31, 2026 1.04 1.05 1.00 1.02 1.02 95,743
Jul 30, 2026 0.9843 1.05 0.9506 1.03 1.03 82,995
Jul 29, 2026 1.02 1.02 0.9702 0.9842 0.9842 95,070
Jul 28, 2026 1.03 1.03 1.00 1.01 1.01 122,654
Jul 27, 2026 1.05 1.07 1.03 1.05 1.05 85,906
Jul 24, 2026 1.06 1.07 1.03 1.04 1.04 85,107
Jul 23, 2026 1.06 1.11 1.06 1.07 1.07 108,776
Jul 22, 2026 1.12 1.13 1.06 1.06 1.06 248,026
Jul 21, 2026 1.08 1.14 1.08 1.13 1.13 456,579
Jul 20, 2026 1.02 1.11 0.9962 1.08 1.08 566,741
Jul 17, 2026 0.9749 1.05 0.9458 1.03 1.03 759,538
Jul 16, 2026 0.8959 1.01 0.8938 0.9999 0.9999 980,554
Jul 15, 2026 0.9735 1.02 0.8400 0.8901 0.8901 26,208,876
Jul 14, 2026 0.9913 1.03 0.9913 1.03 1.03 107,322
Jul 13, 2026 1.02 1.02 0.9957 1.00 1.00 108,524
Jul 10, 2026 1.06 1.06 1.01 1.02 1.02 65,039
Jul 9, 2026 1.10 1.10 1.01 1.04 1.04 176,787
Jul 8, 2026 1.00 1.10 1.00 1.08 1.08 299,272
Jul 7, 2026 1.02 1.02 0.9774 1.01 1.01 154,365
Jul 6, 2026 0.9901 1.03 0.9900 0.9900 0.9900 148,797
Jul 2, 2026 1.01 1.04 1.00 1.00 1.00 168,581
Jul 1, 2026 1.02 1.05 1.00 1.00 1.00 146,746
Jun 30, 2026 1.02 1.05 1.01 1.02 1.02 221,107
Jun 29, 2026 0.9700 1.01 0.9695 0.9850 0.9850 100,591
Jun 26, 2026 0.9648 1.00 0.9601 0.9700 0.9700 141,263
Jun 25, 2026 1.03 1.04 0.9598 0.9598 0.9598 430,277
Jun 24, 2026 1.04 1.06 1.01 1.02 1.02 423,817
Jun 23, 2026 1.04 1.07 1.04 1.04 1.04 283,355
Jun 22, 2026 1.04 1.08 1.04 1.05 1.05 236,424
Jun 18, 2026 1.09 1.10 1.03 1.03 1.03 257,247
Jun 17, 2026 1.08 1.12 1.07 1.08 1.08 146,251
Jun 16, 2026 1.09 1.12 1.06 1.06 1.06 191,111
Jun 15, 2026 1.09 1.12 1.08 1.10 1.10 211,891
Jun 12, 2026 1.07 1.09 1.07 1.07 1.07 106,554
Jun 11, 2026 1.08 1.08 1.05 1.08 1.08 177,714
Jun 10, 2026 1.08 1.10 1.06 1.06 1.06 192,326
Jun 9, 2026 1.09 1.13 1.07 1.08 1.08 177,188
Jun 8, 2026 1.07 1.10 1.05 1.09 1.09 225,525
Jun 5, 2026 1.11 1.13 1.05 1.06 1.06 126,428
Jun 4, 2026 1.11 1.15 1.09 1.14 1.14 91,769
Jun 3, 2026 1.12 1.12 1.09 1.11 1.11 55,777
Jun 2, 2026 1.13 1.13 1.10 1.12 1.12 100,867
Jun 1, 2026 1.08 1.14 1.08 1.13 1.13 262,372
May 29, 2026 1.14 1.14 1.11 1.11 1.11 108,022
May 28, 2026 1.10 1.14 1.10 1.14 1.14 117,284
May 27, 2026 1.08 1.12 1.07 1.10 1.10 136,779
May 26, 2026 1.09 1.11 1.08 1.08 1.08 184,325
May 22, 2026 1.09 1.13 1.09 1.09 1.09 115,880
May 21, 2026 1.07 1.09 1.07 1.09 1.09 45,976
May 20, 2026 1.06 1.08 1.06 1.08 1.08 56,502
May 19, 2026 1.09 1.10 1.06 1.06 1.06 78,731
May 18, 2026 1.07 1.10 1.06 1.08 1.08 122,222
May 15, 2026 1.10 1.11 1.05 1.07 1.07 228,665
May 14, 2026 1.13 1.15 1.10 1.12 1.12 108,285
May 13, 2026 1.12 1.15 1.10 1.13 1.13 127,282
May 12, 2026 1.11 1.12 1.08 1.10 1.10 150,355
May 11, 2026 1.09 1.11 1.07 1.08 1.08 152,476
May 8, 2026 1.15 1.15 1.04 1.07 1.07 324,303
May 7, 2026 1.15 1.17 1.14 1.14 1.14 99,569
May 6, 2026 1.15 1.18 1.14 1.15 1.15 146,903
May 5, 2026 1.18 1.19 1.13 1.13 1.13 119,718
May 4, 2026 1.14 1.18 1.12 1.16 1.16 212,806
May 1, 2026 1.21 1.22 1.13 1.14 1.14 312,670
Apr 30, 2026 1.21 1.23 1.19 1.22 1.22 81,441
Apr 29, 2026 1.20 1.21 1.18 1.18 1.18 63,136
Apr 28, 2026 1.21 1.22 1.20 1.20 1.20 63,874
Apr 27, 2026 1.18 1.22 1.18 1.21 1.21 86,016
Apr 24, 2026 1.24 1.24 1.18 1.19 1.19 230,505
Apr 23, 2026 1.26 1.26 1.22 1.23 1.23 187,709
Apr 22, 2026 1.24 1.27 1.24 1.25 1.25 81,322
Apr 21, 2026 1.26 1.27 1.24 1.25 1.25 93,631
Apr 20, 2026 1.30 1.30 1.25 1.27 1.27 91,214
Apr 17, 2026 1.29 1.31 1.27 1.29 1.29 103,718
Apr 16, 2026 1.33 1.33 1.27 1.27 1.27 146,598
Apr 15, 2026 1.27 1.34 1.25 1.32 1.32 137,078
Apr 14, 2026 1.22 1.30 1.22 1.29 1.29 240,184
Apr 13, 2026 1.21 1.27 1.20 1.24 1.24 161,876
Apr 10, 2026 1.24 1.26 1.21 1.21 1.21 188,257
Apr 9, 2026 1.25 1.28 1.25 1.25 1.25 60,628
Apr 8, 2026 1.30 1.30 1.25 1.30 1.30 139,747
Apr 7, 2026 1.27 1.27 1.24 1.24 1.24 89,498
Apr 6, 2026 1.26 1.29 1.24 1.26 1.26 159,532
Apr 2, 2026 1.26 1.31 1.26 1.28 1.28 100,933
Apr 1, 2026 1.22 1.35 1.22 1.30 1.30 475,747
Mar 31, 2026 1.21 1.27 1.21 1.22 1.22 205,843
Mar 30, 2026 1.28 1.30 1.17 1.20 1.20 527,276
Mar 27, 2026 1.28 1.31 1.22 1.26 1.26 290,074
Mar 26, 2026 1.27 1.35 1.26 1.26 1.26 424,948
Mar 25, 2026 1.23 1.28 1.23 1.26 1.26 187,983
Mar 24, 2026 1.24 1.27 1.22 1.22 1.22 210,122
Mar 23, 2026 1.22 1.31 1.21 1.25 1.25 662,729
Mar 20, 2026 1.18 1.23 1.18 1.22 1.22 257,763
Mar 19, 2026 1.17 1.24 1.13 1.18 1.18 304,450
Mar 18, 2026 1.26 1.26 1.18 1.20 1.20 228,243
Mar 17, 2026 1.26 1.27 1.22 1.27 1.27 264,081
Mar 16, 2026 1.21 1.29 1.19 1.26 1.26 509,352
Mar 13, 2026 1.26 1.29 1.17 1.17 1.17 368,266
Mar 12, 2026 1.26 1.29 1.23 1.25 1.25 390,721
Mar 11, 2026 1.23 1.26 1.19 1.26 1.26 287,098
Mar 10, 2026 1.22 1.25 1.18 1.23 1.23 342,775
Mar 9, 2026 1.15 1.25 1.14 1.21 1.21 390,743
Mar 6, 2026 1.17 1.23 1.15 1.16 1.16 328,399
Mar 5, 2026 1.16 1.22 1.15 1.17 1.17 659,959
Mar 4, 2026 1.05 1.15 1.04 1.15 1.15 861,325
Mar 3, 2026 1.00 1.05 0.9780 1.01 1.01 462,096
Mar 2, 2026 1.07 1.08 1.01 1.02 1.02 638,323
Feb 27, 2026 1.06 1.16 1.06 1.14 1.14 550,346
Feb 26, 2026 1.06 1.10 1.03 1.07 1.07 300,928
Feb 25, 2026 1.09 1.12 1.05 1.05 1.05 474,055
Feb 24, 2026 1.04 1.12 1.01 1.08 1.08 769,724
Feb 23, 2026 1.03 1.06 1.00 1.02 1.02 501,415
Feb 20, 2026 1.15 1.16 1.02 1.03 1.03 1,030,619
Feb 19, 2026 1.19 1.26 1.07 1.14 1.14 1,347,548
Feb 18, 2026 1.42 1.46 1.12 1.16 1.16 2,927,606
Feb 17, 2026 1.58 1.63 1.40 1.47 1.47 2,806,466
Feb 13, 2026 1.22 1.88 1.22 1.65 1.65 24,202,997
Feb 12, 2026 1.28 1.34 1.20 1.22 1.22 3,539,889
Feb 11, 2026 1.29 1.44 1.19 1.29 1.29 15,453,404
Feb 10, 2026 1.41 1.48 1.12 1.12 1.12 162,698,240
Feb 9, 2026 0.9300 0.9300 0.8805 0.9000 0.9000 102,420
Feb 6, 2026 0.8400 0.9299 0.8400 0.9201 0.9201 123,558
Feb 5, 2026 0.9100 0.9160 0.8127 0.8568 0.8568 423,400
Feb 4, 2026 0.9800 0.9800 0.9142 0.9250 0.9250 318,958
Feb 3, 2026 0.9800 0.9997 0.9402 0.9786 0.9786 171,983
Feb 2, 2026 1.00 1.01 0.9700 0.9871 0.9871 285,404
Jan 30, 2026 1.02 1.02 1.00 1.01 1.01 240,058
Jan 29, 2026 1.03 1.03 1.00 1.02 1.02 189,388
Jan 28, 2026 1.04 1.05 1.01 1.02 1.02 132,955
Jan 27, 2026 1.03 1.06 1.01 1.03 1.03 220,972
Jan 26, 2026 1.09 1.09 1.03 1.04 1.04 187,090
Jan 23, 2026 1.09 1.09 1.04 1.09 1.09 202,786
Jan 22, 2026 1.06 1.10 1.05 1.08 1.08 316,472
Jan 21, 2026 1.06 1.07 1.01 1.04 1.04 383,161
Jan 20, 2026 1.10 1.22 1.01 1.08 1.08 1,358,950
Jan 16, 2026 1.14 1.15 1.11 1.14 1.14 136,202
Jan 15, 2026 1.14 1.14 1.09 1.13 1.13 137,004
Jan 14, 2026 1.17 1.17 1.12 1.12 1.12 241,237
Jan 13, 2026 1.18 1.18 1.14 1.18 1.18 116,290
Jan 12, 2026 1.18 1.19 1.12 1.19 1.19 241,641
Jan 9, 2026 1.20 1.20 1.14 1.16 1.16 140,306
Jan 8, 2026 1.20 1.21 1.17 1.19 1.19 185,264
Jan 7, 2026 1.13 1.22 1.12 1.21 1.21 438,321
Jan 6, 2026 1.20 1.20 1.12 1.15 1.15 458,693
Jan 5, 2026 1.10 1.20 1.10 1.17 1.17 1,567,972
Jan 2, 2026 1.05 1.10 1.02 1.09 1.09 403,272
Dec 31, 2025 1.02 1.05 1.02 1.05 1.05 301,200
Dec 30, 2025 1.05 1.06 1.02 1.02 1.02 345,422
Dec 29, 2025 1.08 1.08 1.04 1.06 1.06 237,884
Dec 26, 2025 1.07 1.08 1.03 1.08 1.08 207,315
Dec 24, 2025 1.02 1.05 1.02 1.05 1.05 100,760
Dec 23, 2025 1.09 1.10 1.00 1.03 1.03 1,190,882
Dec 22, 2025 1.08 1.18 1.08 1.10 1.10 401,762
Dec 19, 2025 1.09 1.10 1.04 1.07 1.07 422,634
Dec 18, 2025 1.05 1.13 1.05 1.06 1.06 324,924
Dec 17, 2025 1.07 1.13 1.06 1.07 1.07 210,275
Dec 16, 2025 1.07 1.09 1.04 1.08 1.08 187,883
Dec 15, 2025 1.14 1.14 1.07 1.09 1.09 120,567
Dec 12, 2025 1.16 1.17 1.12 1.12 1.12 183,973
Dec 11, 2025 1.17 1.18 1.14 1.14 1.14 123,294
Dec 10, 2025 1.14 1.20 1.13 1.17 1.17 222,895
Dec 9, 2025 1.16 1.17 1.07 1.15 1.15 696,651
Dec 8, 2025 1.31 1.31 1.12 1.13 1.13 1,006,961
Dec 5, 2025 1.37 1.43 1.31 1.31 1.31 283,111
Dec 4, 2025 1.29 1.37 1.25 1.35 1.35 378,418
Dec 3, 2025 1.22 1.32 1.19 1.29 1.29 703,176
Dec 2, 2025 1.24 1.27 1.21 1.23 1.23 287,030
Dec 1, 2025 1.23 1.30 1.22 1.25 1.25 143,557
Nov 28, 2025 1.24 1.29 1.22 1.26 1.26 92,077
Nov 26, 2025 1.21 1.29 1.20 1.23 1.23 374,904
Nov 25, 2025 1.15 1.24 1.13 1.20 1.20 364,490
Nov 24, 2025 1.15 1.25 1.12 1.16 1.16 511,940
Nov 21, 2025 1.21 1.21 1.08 1.12 1.12 565,553
Nov 20, 2025 1.25 1.29 1.18 1.19 1.19 466,011
Nov 19, 2025 1.27 1.31 1.20 1.25 1.25 558,832
Nov 18, 2025 1.30 1.31 1.21 1.27 1.27 489,122
Nov 17, 2025 1.30 1.33 1.26 1.32 1.32 333,458
Nov 14, 2025 1.36 1.40 1.28 1.30 1.30 483,550
Nov 13, 2025 1.58 1.58 1.36 1.43 1.43 773,128
Nov 12, 2025 1.60 1.64 1.52 1.58 1.58 626,071
Nov 11, 2025 1.55 1.64 1.50 1.61 1.61 482,161
Nov 10, 2025 1.53 1.62 1.52 1.55 1.55 678,776
Nov 7, 2025 1.53 1.58 1.35 1.56 1.56 2,382,454
Nov 6, 2025 1.53 1.59 1.45 1.48 1.48 972,362
Nov 5, 2025 1.61 1.69 1.51 1.58 1.58 1,473,547
Nov 4, 2025 1.77 1.80 1.60 1.63 1.63 2,322,231
Nov 3, 2025 3.47 4.19 1.72 1.86 1.86 162,066,193
Oct 31, 2025 2.01 2.06 1.99 2.05 2.05 72,809
Oct 30, 2025 2.08 2.10 2.00 2.06 2.06 62,027
Oct 29, 2025 2.14 2.15 2.02 2.06 2.06 46,911
Oct 28, 2025 2.18 2.18 2.12 2.16 2.16 61,947
Oct 27, 2025 2.13 2.18 2.08 2.16 2.16 59,266
Oct 24, 2025 2.10 2.16 2.09 2.12 2.12 27,974
Oct 23, 2025 2.09 2.16 2.06 2.14 2.14 46,885
Oct 22, 2025 2.11 2.12 2.06 2.11 2.11 66,053
Oct 21, 2025 2.16 2.16 2.11 2.13 2.13 22,716
Oct 20, 2025 2.14 2.17 2.11 2.16 2.16 50,176
Oct 17, 2025 2.12 2.16 2.09 2.11 2.11 40,108
Oct 16, 2025 2.20 2.25 2.10 2.12 2.12 81,525
Oct 15, 2025 2.25 2.25 2.16 2.24 2.24 126,792
Oct 14, 2025 2.13 2.23 2.07 2.22 2.22 61,629
Oct 13, 2025 2.20 2.25 2.17 2.18 2.18 70,864
Oct 10, 2025 2.37 2.40 2.20 2.20 2.20 131,767
Oct 9, 2025 2.45 2.45 2.33 2.36 2.36 57,259
Oct 8, 2025 2.37 2.45 2.33 2.42 2.42 106,836
Oct 7, 2025 2.33 2.35 2.30 2.35 2.35 57,739
Oct 6, 2025 2.26 2.37 2.26 2.36 2.36 90,829
Oct 3, 2025 2.41 2.45 2.33 2.39 2.39 77,755
Oct 2, 2025 2.42 2.42 2.30 2.39 2.39 118,492
Oct 1, 2025 2.40 2.48 2.38 2.42 2.42 76,847
Sep 30, 2025 2.56 2.56 2.32 2.48 2.48 552,442
Sep 29, 2025 2.26 2.39 2.13 2.36 2.36 658,563
Sep 26, 2025 2.23 2.26 2.16 2.23 2.23 92,026
Sep 25, 2025 2.23 2.25 2.16 2.20 2.20 58,016
Sep 24, 2025 2.17 2.24 2.15 2.23 2.23 41,200
Sep 23, 2025 2.25 2.26 2.13 2.17 2.17 118,188
Sep 22, 2025 2.18 2.24 2.12 2.24 2.24 113,340

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Phio Pharmaceuticals Corp. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at PHIO, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation